您的当前位置:
首页 >
研究报告 >
公司调研 > 预览报告
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=4117497","PageTitle":"2022三季报点评:Q3业绩超预期,各业务管线保持高增速-公司调研 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":19,"Face":"/_files/face/0/1zcnzrk7.jpg","UName":"郦问风","UpArts":0,"UpRpts":23196,"UpLbies":35},"Rid":4117497,"IsPdf":true,"IsExist":true,"PdfUrl":"/download2.mtachn.com/upload/report/公司调研/20221026-东吴证券-百诚医药-301096.SZ-2022三季报点评Q3业绩超预期各业务管线保持高增速.pdf","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}